Forootan SS - Search Results

1

Increased expression of Id family proteins in small cell lung cancer and its prognostic significance.

Kamalian L, Gosney JR, Forootan SS, Foster CS, Bao ZZ, Beesley C, Ke Y. Kamalian L, et al. Among authors: forootan ss. Clin Cancer Res. 2008 Apr 15;14(8):2318-25. doi: 10.1158/1078-0432.CCR-07-4716. Clin Cancer Res. 2008. PMID: 18413820

2

Basic fibroblast growth factor and angiogenesis in squamous carcinoma of the tongue.

Forootan SS, Ke Y, Jones AS, Helliwell TR. Forootan SS, et al. Oral Oncol. 2000 Sep;36(5):437-43. doi: 10.1016/s1368-8375(00)00032-4. Oral Oncol. 2000. PMID: 10964050

3

Prognostic significance of osteopontin expression in human prostate cancer.

Forootan SS, Foster CS, Aachi VR, Adamson J, Smith PH, Lin K, Ke Y. Forootan SS, et al. Int J Cancer. 2006 May 1;118(9):2255-61. doi: 10.1002/ijc.21619. Int J Cancer. 2006. PMID: 16331611

4

Ribosomal protein l19 is a prognostic marker for human prostate cancer.

Bee A, Ke Y, Forootan S, Lin K, Beesley C, Forrest SE, Foster CS. Bee A, et al. Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2061-5. doi: 10.1158/1078-0432.CCR-05-2445. Clin Cancer Res. 2006. PMID: 16609016

5

Increased expression of anterior gradient-2 is significantly associated with poor survival of prostate cancer patients.

Zhang Y, Forootan SS, Liu D, Barraclough R, Foster CS, Rudland PS, Ke Y. Zhang Y, et al. Among authors: forootan ss. Prostate Cancer Prostatic Dis. 2007;10(3):293-300. doi: 10.1038/sj.pcan.4500960. Epub 2007 Apr 24. Prostate Cancer Prostatic Dis. 2007. PMID: 17457305

6

Increased Id-1 expression is significantly associated with poor survival of patients with prostate cancer.

Forootan SS, Wong YC, Dodson A, Wang X, Lin K, Smith PH, Foster CS, Ke Y. Forootan SS, et al. Hum Pathol. 2007 Sep;38(9):1321-9. doi: 10.1016/j.humpath.2007.02.011. Epub 2007 Jun 28. Hum Pathol. 2007. PMID: 17599389

7

Expression of cutaneous fatty acid-binding protein (C-FABP) in prostate cancer: potential prognostic marker and target for tumourigenicity-suppression.

Morgan EA, Forootan SS, Adamson J, Foster CS, Fujii H, Igarashi M, Beesley C, Smith PH, Ke Y. Morgan EA, et al. Among authors: forootan ss. Int J Oncol. 2008 Apr;32(4):767-75. Int J Oncol. 2008. PMID: 18360704

8

Atelocollagen-delivered siRNA targeting the FABP5 gene as an experimental therapy for prostate cancer in mouse xenografts.

Forootan SS, Bao ZZ, Forootan FS, Kamalian L, Zhang Y, Bee A, Foster CS, Ke Y. Forootan SS, et al. Among authors: forootan fs. Int J Oncol. 2010 Jan;36(1):69-76. Int J Oncol. 2010. PMID: 19956834

9

Inhibition of tumourigenicity of small cell lung cancer cells by suppressing Id3 expression.

Kamalian L, Forootan SS, Bao ZZ, Zhang Y, Gosney JR, Foster CS, Ke Y. Kamalian L, et al. Among authors: forootan ss. Int J Oncol. 2010 Sep;37(3):595-603. doi: 10.3892/ijo_00000708. Int J Oncol. 2010. PMID: 20664928 Free article.

10

Suppressing tumourigenicity of prostate cancer cells by inhibiting osteopontin expression.

Zhang Y, Forootan SS, Kamalian L, Bao ZZ, Malki MI, Foster CS, Ke Y. Zhang Y, et al. Among authors: forootan ss. Int J Oncol. 2011 Apr;38(4):1083-91. doi: 10.3892/ijo.2011.932. Epub 2011 Feb 2. Int J Oncol. 2011. PMID: 21290088

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters